Our Approach

More information on our approach for specific targeting and killing of cancer cells.

More ›

Our Team

More information about our team we are building to bring this product to market.

More ›

Our Pipeline

For more information on our current pipeline of products we are developing.

More ›

Inform me about new updates ›

New Articles

Georgia Research Alliance Awards Annate/Hajduk Lab Phase Ic Funding

In recognition of the significant strides made in Phase Ia and Phase Ib, the Georgia Research Alliance has awarded a $25,000 Phase Ic grant to Annate Bitherapeutics and the Hajduk Lab at the University of Georgia. This grant will specifically support the advancement of proof-of-concept animal studies, a critical step in the development of their innovative therapeutic against Multiple Myeloma. Read More ›